St. Jude scientists and clinicians work together to translate laboratory breakthroughs into novel treatment options for pediatric catastrophic diseases.
To schedule an interview, email media@stjude.org.
Drug Discovery and Translational Therapeutics Experts
-
Aseem Z. Ansari
Ansari
Aseem Ansari, PhD, St. Jude Department of Chemical Biology & Therapeutics chair, is an expert in therapeutics that target transcription factors—proteins that regulate gene activation. His research focuses on building and studying synthetic gene regulators (SynGRs) used as therapeutics for personalized medicine.
-
Daniel J. Blair, PhD
Blair
Daniel Blair, PhD, St. Jude Department of Chemical Biology & Therapeutics, designs covalent chemical matter that reacts and interacts with biological machinery. Through this, Blair seeks to identify new therapeutic targets and prolong the action of current medicines.
-
Frank Fazio
Fazio
Frank Fazio, Children’s GMP, LLC, president and St. Jude vice president of therapeutics production and quality, leads the biologic manufacturing facility at St. Jude. The GMP allows St. Jude to develop and produce innovative treatments for its patients that may not find an initial investment by a major pharmaceutical company.
-
David Rogers, PharmD, PhD, St. Jude Department of Pharmacy and Pharmaceutical Sciences chair, seeks to define the resistance mechanisms of pathogenic fungi to antifungal drugs, a vital step in developing improved treatment for fungal infections, especially in immunocompromised patients.
-
Anang A. Shelat, PhD
Shelat
Anang Shelat, PhD, St. Jude Department of Chemical Biology & Therapeutics, is an expert in chemical informatics and translational drug discovery. His research program seeks to understand the mechanisms of drug action to optimize therapies and target disease vulnerabilities.
